His clinical practice mainly focuses on urogenital malignant tumors, precision medicine and developmental therapeutics. He is trained as a pharmaceutical scientist and clinical pharmacologist, with expertise in precision medicine/pharmacogenetics, developmental therapeutics and epigenetics. His primary career goal is to optimize the treatment strategy of blood/tumor patients by integrating epigenetics, developmental therapeutics and clinical pharmacology into clinical and translational research, thus promoting public health. His highly cooperative translational research project focuses on the paradigm of functional genomics, which helps to reveal the molecular mechanism of the interaction among genotype, phenotype and epigenetics of patients. Then combine the molecular mechanism information with clinical pharmacology (such as pharmacokinetics and pharmacodynamics) to optimize drug selection and administration.